Log In
person
Intra-Cellular Therapies Inc
ITCI
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma for Neurological Disorders |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
464.37M | 100.00% |
| Pharma for Neurological Disorders |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0M | 0.00% |
| keyboard_arrow_down |
Pharma for Neurological Disorders
Branded Pharmaceuticals (outsourced)
|
464.37M | 100.00% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Pharma for Neurological Disorders
Pre-Revenue Pharmaceuticals
|
0M | 0.00% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||